ASCENT INDUSTRIES CO (ACNT)

US8715651076 - Common Stock

11.01  0 (0%)

Fundamental Rating

3

Taking everything into account, ACNT scores 3 out of 10 in our fundamental rating. ACNT was compared to 155 industry peers in the Metals & Mining industry. ACNT has a great financial health rating, but its profitability evaluates not so good. ACNT has a valuation in line with the averages, but it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

ACNT had negative earnings in the past year.
ACNT had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ACNT reported negative net income in multiple years.
ACNT had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of ACNT (-0.96%) is comparable to the rest of the industry.
ACNT has a Return On Equity (-1.51%) which is in line with its industry peers.
Industry RankSector Rank
ROA -0.96%
ROE -1.51%
ROIC N/A
ROA(3y)-0.17%
ROA(5y)-2.97%
ROE(3y)3.25%
ROE(5y)-5.41%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ACNT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

ACNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
ACNT has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ACNT has been increased compared to 5 years ago.
Compared to 1 year ago, ACNT has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.61 indicates that ACNT is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.61, ACNT is in line with its industry, outperforming 52.90% of the companies in the same industry.
The Debt to FCF ratio of ACNT is 0.34, which is an excellent value as it means it would take ACNT, only 0.34 years of fcf income to pay off all of its debts.
ACNT has a Debt to FCF ratio of 0.34. This is amongst the best in the industry. ACNT outperforms 90.97% of its industry peers.
ACNT has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
ACNT has a Debt to Equity ratio of 0.01. This is in the better half of the industry: ACNT outperforms 73.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.34
Altman-Z 2.61
ROIC/WACCN/A
WACC11.78%

2.3 Liquidity

ACNT has a Current Ratio of 3.77. This indicates that ACNT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.77, ACNT is in the better half of the industry, outperforming 71.61% of the companies in the same industry.
A Quick Ratio of 1.81 indicates that ACNT should not have too much problems paying its short term obligations.
ACNT has a Quick ratio of 1.81. This is comparable to the rest of the industry: ACNT outperforms 58.71% of its industry peers.
Industry RankSector Rank
Current Ratio 3.77
Quick Ratio 1.81

1

3. Growth

3.1 Past

ACNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.53%, which is quite impressive.
The Revenue for ACNT has decreased by -44.99% in the past year. This is quite bad
The Revenue has been decreasing by -7.21% on average over the past years.
EPS 1Y (TTM)62.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.48%
Revenue 1Y (TTM)-44.99%
Revenue growth 3Y-8.96%
Revenue growth 5Y-7.21%
Sales Q2Q%-23.55%

3.2 Future

The Earnings Per Share is expected to grow by 47.73% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -9.74% on average over the next years.
EPS Next Y88.59%
EPS Next 2Y47.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-23.71%
Revenue Next 2Y-9.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACNT. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 13.49 indicates a correct valuation of ACNT.
61.94% of the companies in the same industry are more expensive than ACNT, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.99. ACNT is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 13.49

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACNT indicates a somewhat cheap valuation: ACNT is cheaper than 78.06% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.83
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ACNT's earnings are expected to grow with 47.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.73%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ACNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ASCENT INDUSTRIES CO

NASDAQ:ACNT (12/24/2024, 7:53:52 PM)

11.01

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners31.55%
Inst Owner ChangeN/A
Ins Owners13.62%
Ins Owner Change3.73%
Market Cap111.09M
Analysts85.71
Price Target18.36 (66.76%)
Short Float %0.15%
Short Ratio0.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-60.48%
Min EPS beat(2)-212.04%
Max EPS beat(2)91.09%
EPS beat(4)1
Avg EPS beat(4)-245.79%
Min EPS beat(4)-819.12%
Max EPS beat(4)91.09%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-16.78%
Min Revenue beat(2)-25.03%
Max Revenue beat(2)-8.54%
Revenue beat(4)1
Avg Revenue beat(4)-15.32%
Min Revenue beat(4)-36.37%
Max Revenue beat(4)8.66%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.49
P/S 0.76
P/FCF 18.83
P/OCF 15
P/B 1.17
P/tB 1.27
EV/EBITDA N/A
EPS(TTM)-1.39
EYN/A
EPS(NY)0.82
Fwd EY7.41%
FCF(TTM)0.58
FCFY5.31%
OCF(TTM)0.73
OCFY6.67%
SpS14.49
BVpS9.39
TBVpS8.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.96%
ROE -1.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 4.04%
ROA(3y)-0.17%
ROA(5y)-2.97%
ROE(3y)3.25%
ROE(5y)-5.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.34
Debt/EBITDA N/A
Cap/Depr 20.6%
Cap/Sales 1.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.77
Quick Ratio 1.81
Altman-Z 2.61
F-Score6
WACC11.78%
ROIC/WACCN/A
Cap/Depr(3y)30.67%
Cap/Depr(5y)33.68%
Cap/Sales(3y)1.06%
Cap/Sales(5y)1.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.48%
EPS Next Y88.59%
EPS Next 2Y47.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.99%
Revenue growth 3Y-8.96%
Revenue growth 5Y-7.21%
Sales Q2Q%-23.55%
Revenue Next Year-23.71%
Revenue Next 2Y-9.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-92.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1785.71%
FCF growth 3Y12.37%
FCF growth 5YN/A
OCF growth 1Y91.87%
OCF growth 3Y8.68%
OCF growth 5YN/A